We found that a combination of the urinary levels of ganglioside GM2 activator protein (GM2AP) and chaperonin containing TCP-1, subunit eta (TCP1-eta) best associates to recovery from AKI, specifically within the sub-population of renal AKI patients. This evidence concerns the gene GM2A and acute kidney injury.